{"doi":"10.1001/jama.2021.24757","title":"Platelet-Rich Plasma Injections vs Placebo for Patients With Ankle Osteoarthritis—Reply","abstract":"HCV testing, and 10.7% (n = 188) offered HCV treatment.Among non-OTPs in 2020, 46.6% (n = 3024) offered HIV testing, 17.9% (n = 1163) offered HIV treatment, 45.8% (n = 2976) offered HCV testing, and 20.5% (n = 1334) offered HCV treatment.For both OTPs and non-OTPs, HIV and HCV testing and treatment were most often available in federally owned facilities and facilities with inpatient services, with the proportion of outpatient-only facilities providing such services being low (Table 2).Of the 117 OTPs in the 7 Ending the HIV Epidemic highpriority rural states in 2020, 46.2% (n = 54) and 4.3% (n = 5) offered HIV testing and treatment, respectively.Discussion | Despite an increasing number of substance use disorder treatment facilities that offered medication for opioid use disorder, the proportion of facilities that also offered HIV and HCV testing did not change between 2017 and 2020.In 2020, only half of the facilities offered HIV and HCV testing.The stagnant trends, including among OTPs, are troubling, as a prior study found declines in HIV testing availability among OTPs between 2000 and 2011. 5egardless of OTP status, HIV and HCV testing and treatment availability was particularly low in outpatient-only facilities that can potentially establish routine care and in highpriority rural states with increasing HIV/HCV risk. 3,6 Limitations of the study include that the findings may not be generalizable to clinicians who prescribe medication to treat opioid use disorder outside of the specialty treatment system.While integration of medication for opioid use disorder into primary care and infectious disease clinics remains important, these data highlight that increased efforts are needed to better integrate HIV and HCV testing and treatment in the specialty treatment system.","journal":"JAMA","year":2022,"id":293582,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9499,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":978301,"name":"Gustaaf Reurink","orcid":"0000-0002-4299-7780","position":1,"is_corresponding":false},{"id":978302,"name":"Johannes L. Tol","orcid":"0000-0001-5322-8445","position":2,"is_corresponding":false},{"id":978300,"name":"Liam D. A. Paget","orcid":"0000-0002-0062-9701","position":0,"is_corresponding":true}],"reference_count":6,"raw_metadata":null,"created_at":"2026-07-19T00:30:53.818562Z","pmid":"35191929","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}